Top Gainers & Losers: Tata Consumer Products Surges, Tuesday, October 27, 2026
Indian equities traded on a mixed note on Tuesday, October 27, 2026. While domestic buying interest provided support to selective FMCG, defense, and automobile names, selling pressure across information technology and healthcare heavyweights capped broader upside.
Top Nifty 50 Gainers Today
- Tata Consumer Products Ltd: up 5.69%
- Bajaj Auto Ltd: up 2.77%
- Bharat Electronics Ltd (BEL): up 2.63%
- Bharti Airtel Ltd: up 2.44%
Top Nifty 50 Losers Today
- Infosys Ltd: down 2.18%
- Hindalco Industries Ltd: down 2.14%
- Cipla Ltd: down 1.99%
- Asian Paints Ltd: down 1.88%
Analysis: Reasons Behind the Moves
- Tata Consumer Products: The stock led the market rally after reporting strong financial results for the second quarter. Consolidated net profit rose 16% year-on-year, accompanied by a 14% year-on-year increase in revenue from operations. The upside was driven by healthy 11% underlying volume expansion in the India branded portfolio and a 40% surge across its fast-growing food and beverage segments.
- Bharat Electronics Ltd (BEL): BEL saw solid buying interest following positive developments on order execution and capacity expansion, including fresh contract wins and capital expenditure plans for a major defense manufacturing hub.
- Bajaj Auto: The stock gained as the broader automotive basket traded with strength, supported by positive institutional sentiment and positioning ahead of quarterly performance disclosures.
- Infosys: Heavyweight technology shares faced fresh headwinds, leading losses in the benchmark as IT counters experienced profit booking following a run-up earlier in the month.
- Hindalco Industries: The metal major declined under the weight of weak technical momentum and caution over commodity demand.
- Cipla: Selling pressure intensified after the pharmaceutical major reported a 35% year-on-year decline in consolidated net profit for the second quarter. The decline was primarily weighed down by a 19% drop in North American sales due to heightened competitive pressures on key generic products.